Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis

Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis

Abstract The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older persons with MS may be more susceptible to infections, hospitalisations and malignancy. Aging people with MS have high...

Full description

Bibliographic Details
Main Authors: Jerome de Seze, Dominique Dive, Xavier Ayrignac, Giovanni Castelnovo, Marianne Payet, Amel Rayah, Claudio Gobbi, Patrick Vermersch, Chiara Zecca
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-04-01
Series:Neurology and Therapy
Subjects:
Cladribine tablets
Relapsing multiple sclerosis
Disease-modifying therapy
Ageing
Online Access:https://doi.org/10.1007/s40120-024-00603-y

Internet

https://doi.org/10.1007/s40120-024-00603-y

Similar Items